The glycocalyx and trauma: A review

Shock

Volumn 45, Issue 4, 2016, Pages 338-348

  Chignalia, Andreia Z ^a   Yetimakman, Feliz ^b   Christiaans, Sarah C ^c   Unal, Sule ^b   Bayrakci, Benan ^b   Wagener, Brant M ^c   Russell, Robert T ^d   Kerby, Jeffrey D ^d   Pittet, Jean Francois ^c,d   Dull, Randal O ^a,e  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e University of Illinois at Chicago   (United States)

Author keywords

Endothelium; Epithelium; Glycocalyx; Glypican; Heparan sulfates; Inflammation; Pneumonia; Syndecan; Trauma; Wounds

Indexed keywords

HYALURONIC ACID; SYNDECAN;

BACTERIAL PNEUMONIA; GLYCOCALYX; HUMAN; LUNG INJURY; NONHUMAN; PNEUMONIA; REVIEW; RISK FACTOR; ADOLESCENT; ADULT; AGE; ANIMAL; CHILD; ECONOMICS; EPIDEMIOLOGY; EPITHELIUM; FEMALE; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; INJURY SCALE; MALE; MORTALITY; PRESCHOOL CHILD; PROCEDURES; RESUSCITATION; UNITED STATES; VASCULAR ENDOTHELIUM; WOUNDS AND INJURIES;

ADOLESCENT; ADULT; AGE FACTORS; ANIMALS; CHILD; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; EPITHELIUM; FEMALE; GLYCOCALYX; HUMANS; IMMUNOMODULATION; INFLAMMATION; MALE; RESUSCITATION; TRAUMA SEVERITY INDICES; UNITED STATES; WOUNDS AND INJURIES;

EID: 84945578970     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000513     Document Type: Review

References (96)

1. Collins SR, Blank RS, Deatherage LS, Dull RO: Special article: the endothelial glycocalyx: emerging concepts in pulmonary edema and acute lung injury. Anesth Analg 117(3):664-674, 2013.
2. Lipowsky HH: The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Ann Biomed Eng 40(4):840-848, 2012.
3. Pries A, Kuebler W: Normal endothelium. Handb Exp Pharmacol 176:1-40, 2006.
4. Mulivor AW, Lipowsky HH: Inhibition of glycan shedding and leukocyteendothelial adhesion in postcapillary venules by suppression of matrix metalloprotease activity with doxycycline. Microcirculation 16(8):657-666, 2009.
5. Mulivor AW, Lipowsky HH: Inflammation-and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol 286(5):H1672-H1680, 2004.
6. Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L, Zemans RL, Bowman JC, Koyanagi DE, Yunt ZX, et al.: The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 18(8):1217-1223, 2012.
7. Dudek SM, Garcia JG: Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol (1985) 91(4):1487-1500, 2001.
8. Dull RO, Cluff M, Kingston J, Hill D, Chen H, Hoehne S, Malleske DT, Kaur R: Lung heparan sulfates modulate K(fc) during increased vascular pressure: evidence for glycocalyx-mediated mechanotransduction. Am J Physiol Lung Cell Mol Physiol 302(9):L816-L828, 2012.
9. Park PW, Pier GB, Hinkes MT, Bernfield M: Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 411(6833):98-102, 2001.
10. Johnson GB, Brunn GJ, Kodaira Y, Platt JL: Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4. J Immunol 168(10):5233-5239, 2002.
11. Xu D, Young J, Song D, Esko JD: Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE). J Biol Chem 286(48):41736-41744, 2011.
12. Xu D, Young JH, Krahn JM, Song D, Corbett KD, Chazin WJ, Pedersen LC, Esko JD: Stable rage-heparan sulfate complexes are essential for signal transduction. ACS Chem Biol 8(7):1611-1620, 2013.
13. Ostrowski SR, Johansson PI: Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg 73(1):60-66, 2012.
14. Pierce A, Pittet JF: Inflammatory response to trauma: implications for coagulation and resuscitation. Curr Opin Anaesthesiol 27(2):246-252, 2014.
15. Darwiche SS, Ruan X, Hoffman MK, Zettel KR, Tracy AP, Schroeder LM, Cai C, Hoffman RA, Scott MJ, Pape HC, et al.: Selective roles for toll-like receptors 2, 4, and 9 in systemic inflammation and immune dysfunction following peripheral tissue injury. J Trauma Acute Care Surg 74(6):1454-1461, 2013.
16. Johansson P, Stensballe J, Rasmussen L, Ostrowski S: A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein c depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 254:194-200, 2011.
17. Rahbar E, Cardenas JC, Baimukanova G, Usadi B, Bruhn R, Pati S, Ostrowski SR, Johansson PI, Holcomb JB,Wade CE: Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients. J Transl Med 13:117, 2015.
18. Edwards JR, Peterson KD, Andrus ML, Tolson JS, Goulding JS, Dudeck MA, Mincey RB, Pollock DA, Horan TC, Facilities N: National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007. Am J Infect Control 35(5):290-301, 2007.
19. Voyvodic PL, Min D, Liu R,Williams E, Chitalia V, Dunn AK, Baker AB: Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated response to atheroprotective flow. J Biol Chem 289(14):9547-9559, 2014.
20. Filmus J, Capurro M, Rast J: Glypicans. Genome Biol 9(5):224, 2008.
21. Bartlett AH, Hayashida K, Park PW: Molecular and cellular mechanisms of syndecans in tissue injury and inflammation. Mol Cells 24(2):153-166, 2007.
22. Stevens AP, Hlady V, Dull RO: Fluorescence correlation spectroscopy can probe albumin dynamics inside lung endothelial glycocalyx. Am J Physiol Lung Cell Mol Physiol 293(2):L328-L335, 2007.
23. Choi Y, Chung H, Jung H, Couchman JR, Oh ES: Syndecans as cell surface receptors: unique structure equates with functional diversity. Matrix Biol 30(2):93-99, 2011.
24. Morgan MR, Humphries MJ, Bass MD: Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol 8(12):957-969, 2007.
25. Alexopoulou AN, Multhaupt HA, Couchman JR: Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 39(3):505-528, 2007.
26. Annecke T, Fischer J, Hartmann H, Tschoep J, Rehm M, Conzen P, Sommerhoff CP, Becker BF: Shedding of the coronary endothelial glycocalyx: effects of hypoxia/reoxygenation vs ischaemia/reperfusion. Br J Anaesth 107(5):679-686, 2011.
27. Ebong EE, Lopez-Quintero SV, Rizzo V, Spray DC, Tarbell JM: Shear-induced endothelial NOs activation and remodeling via heparan sulfate, glypican-1, and syndecan-1. Integr Biol (Camb) 6(3):338-347, 2014.
28. Filmus J, Selleck SB: Glypicans: proteoglycans with a surprise. J Clin Invest 108(4):497-501, 2001.
29. Clough G: Relationship between microvascular permeability and ultrastructure. Prog Biophys Mol Biol 55(1):47-69, 1991.
30. Mason JC, Curry FE, Michel CC: The effects of proteins upon the filtration coefficient of individually perfused frog mesenteric capillaries. Microvasc Res 13(2):185-202, 1977.
31. Dull RO, Mecham I, McJames S: Heparan sulfates mediate pressure-induced increase in lung endothelial hydraulic conductivity via nitric oxide/reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 292(6):L1452-L1458, 2007.
32. Curry FE, Adamson RH: Endothelial glycocalyx: permeability barrier and mechanosensor. Ann Biomed Eng 40(4):828-839, 2012.
33. Pries AR, Secomb TW, Gaehtgens P: The endothelial surface layer. Pflugers Arch 440(5):653-666, 2000.
34. Tarbell JM, Ebong EE: The endothelial glycocalyx: a mechano-sensor and-transducer. Sci Signal 1(40):t8, 2008.
35. Florian JA, Kosky JR, Ainslie K, Pang Z, Dull RO, Tarbell JM: Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ Res 93(10):e136-e142, 2003.
36. Zharikov SI, Sigova AA, Chen S, Bubb MR, Block ER: Cytoskeletal regulation of the l-arginine/no pathway in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 280(3):L465-L473, 2001.
37. Chakravarti R, Sapountzi V, Adams JC: Functional role of syndecan-1 cytoplasmic v region in lamellipodial spreading, actin bundling, and cell migration. Mol Biol Cell 16(8):3678-3691, 2005.
38. Kuebler WM, Uhlig U, Goldmann T, Schael G, Kerem A, Exner K, Martin C, Vollmer E, Uhlig S: Stretch activates nitric oxide production in pulmonary vascular endothelial cells in situ. Am J Respir Crit Care Med 168(11):1391-1398, 2003.
39. Ichimura H, Parthasarathi K, Quadri S, Issekutz AC, Bhattacharya J: Mechanooxidative coupling by mitochondria induces proinflammatory responses in lung venular capillaries. J Clin Invest 111(5):691-699, 2003.
40. Ichimura H, Parthasarathi K, Issekutz AC, Bhattacharya J: Pressure-induced leukocyte margination in lung postcapillary venules. Am J Physiol Lung Cell Mol Physiol 289(3):L407-L412, 2005.
41. Adamson RH: Permeability of frog mesenteric capillaries after partial pronase digestion of the endothelial glycocalyx. J Physiol 428:1-13, 1990.
42. Curry FR, Adamson RH: Vascular permeability modulation at the cell, microvessel, or whole organ level: towards closing gaps in our knowledge. Cardiovasc Res 87(2):218-229, 2010.
43. van den Berg BM, Vink H, Spaan JA: The endothelial glycocalyx protects against myocardial edema. Circ Res 92(6):592-594, 2003.
44. Huxley VH, Williams DA: Role of a glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments. Am J Physiol Heart Circ Physiol 278(4):H1177-H1185, 2000.
45. Strunden MS, Bornscheuer A, Schuster A, Kiefmann R, Goetz AE, Heckel K: Glycocalyx degradation causes microvascular perfusion failure in the ex vivo perfused mouse lung: hydroxyethyl starch 130/0.4 pretreatment attenuates this response. Shock 38(5):559-566, 2012.
46. Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, Ko TC, Paredes A: Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 112(6):1289-1295, 2011.
47. Torres Filho I, Torres LN, Sondeen JL, Polykratis IA, Dubick MA: In vivo evaluation of venular glycocalyx during hemorrhagic shock in rats using intravital microscopy. Microvasc Res 85:128-133, 2013.
48. Becker BF, Fischer J, Hartmann H, Chen CC, Sommerhoff CP, Tschoep J, Conzen PC, Annecke T: Inosine, not adenosine, initiates endothelial glycocalyx degradation in cardiac ischemia and hypoxia. Nucleosides Nucleotides Nucleic Acids 30(12):1161-1167, 2011.
49. Chappell D, Heindl B, Jacob M, Annecke T, Chen C, Rehm M, Conzen P, Becker BF: Sevoflurane reduces leukocyte and platelet adhesion after ischemia-reperfusion by protecting the endothelial glycocalyx. Anesthesiology 115(3):483-491, 2011.
50. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Reichart B, et al.: Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 116(17):1896-1906, 2007.
51. Pries AR, Secomb TW, Jacobs H, Sperandio M, Osterloh K, Gaehtgens P: Microvascular blood flow resistance: role of endothelial surface layer. Am J Physiol 273(5 Pt 2):H2272-H2279, 1997.
52. Pries AR, SecombTW, Sperandio M, Gaehtgens P: Blood flow resistance during hemodilution: effect of plasma composition. Cardiovasc Res 37(1):225-235, 1998.
53. Torres LN, Sondeen JL, Ji L, Dubick MA, Torres Filho I: Evaluation of resuscitation fluids on endothelial glycocalyx, venular blood flow, and coagulation function after hemorrhagic shock in rats. J Trauma Acute Care Surg 75(5):759-766, 2013.
54. Constantinescu AA, Vink H, Spaan JA: Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol 23(9):1541-1547, 2003.
55. Chappell D, Dorfler N, Jacob M, Rehm M, Welsch U, Conzen P, Becker BF: Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion. Shock 34(2):133-139, 2010.
56. Chappell D, Brettner F, Doerfler N, Jacob M, Rehm M, Bruegger D, Conzen P, Jacob B, Becker BF: Protection of glycocalyx decreases platelet adhesion after ischaemia/reperfusion: an animal study. Eur J Anaesthesiol 31(9):474-481, 2014.
57. Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M: Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 87(2):300-310, 2010.
58. Chappell D, Jacob M, Hofmann-Kiefer K, Bruegger D, Rehm M, Conzen P, Welsch U, Becker BF: Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 107(5):776-784, 2007.
59. Chappell D, Jacob M, Hofmann-Kiefer K, Rehm M, Welsch U, Conzen P, Becker BF: Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovasc Res 83(2):388-396, 2009.
60. Peng Z, Pati S, Potter D, Brown R, Holcomb JB, Grill R, Wataha K, Park PW, Xue H, Kozar RA: Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1. Shock 40(3):195-202, 2013.
61. Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, Park PW, Wang W, Zaske AM, Menge T, Kozar RA: Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS One 6(8):e23530, 2011.
62. Johansson PI, Sorensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR: Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Crit Care 15(6):R272, 2011.
63. Johansson PI, Sorensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR: Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets, and leukocytes in response to increasing injury severity. Crit Care Med 40(6):1844-1850, 2012.
64. Johansson PI, Ostrowski SR: Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypotheses 75(6):564-567, 2010.
65. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR: High circulating adrenaline levels at admission predict increased mortality after trauma. J Trauma Acute Care Surg 72(2):428-436, 2012.
66. Johansson PI, Sorensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR: High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J Thromb Haemost 10(2):207-216, 2012.
67. Ostrowski SR, Sorensen AM, Windelov NA, Perner A, Welling KL, Wanscher M, Larsen CF, Johansson PI: High levels of soluble VEGF receptor-1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study. Scand J Trauma Resusc Emerg Med 20:27, 2012.
68. Nair GB, Niederman MS: Year in review 2012: critical care-respiratory infections. Crit Care 17(6):251, 2013.
69. Croce MA, Brasel KJ, Coimbra R, Adams CA Jr, Miller PR, Pasquale MD, McDonald CS, Vuthipadadon S, Fabian TC, Tolley EA: National trauma institute prospective evaluation of the ventilator bundle in trauma patients: does it really work? J Trauma Acute Care Surg 74(2):354-360, 2013.
70. Michetti CP, Fakhry SM, Ferguson PL, Cook A, Moore FO, Gross R, AAST Ventilator-Associated Pneumonia Investigators. Ventilator-associated pneumonia rates at major trauma centers compared with a national benchmark: a multiinstitutional study of the AAST. J Trauma Acute Care Surg 72(5):1165-1173, 2012.
71. Barbier F, Andremont A, Wolff M, Bouadma L: Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management. Curr Opin Pulm Med 19(3):216-228, 2013.
72. Harrington DT, Phillips B, Machan J, Zacharias N, Velmahos GC, Rosenblatt MS, Winston E, Patterson L, Desjardins S, Winchell R, et al.:, Research Consortium of New England Centers for T. Factors associated with survival following blunt chest trauma in older patients: results from a large regional trauma cooperative. Arch Surg 145(5):432-437, 2010.
73. Jovanovic B, Milan Z, Markovic-Denic L, Djuric O, Radinovic K, Doklestic K, Velickovic J, Ivancevic N, Gregoric P, Pandurovic M, et al.: Risk factors for ventilator-associated pneumonia in patients with severe traumatic brain injury in serbian trauma centre. Int J Infect Dis 38:46-51, 2015.
74. Patel BV, Wilson MR, Takata M: Resolution of acute lung injury and inflammation: a translational mouse model. Eur Respir J 39(5):1162-1170, 2012.
75. Iskander KN, Craciun FL, Stepien DM, Duffy ER, Kim J, Moitra R, Vaickus LJ, Osuchowski MF, Remick DG: Cecal ligation and puncture-induced murine sepsis does not cause lung injury. Crit Care Med 41(1):159-170, 2013.
76. Carles M, Wagener BM, Lafargue M, Roux J, Iles K, Liu D, Rodriguez CA, Anjum N, Zmijewski J, Ricci JE, et al.: Heat-shock response increases lung injury caused by Pseudomonas aeruginosa via an interleukin-10-dependent mechanism in mice. Anesthesiology 120(6):1450-1462, 2014.
77. Kesimer M, Ehre C, Burns KA, Davis CW, Sheehan JK, Pickles RJ: Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways. Mucosal Immunol 6(2):379-392, 2013.
78. Elfenbein A, Simons M: Syndecan-4 signaling at a glance. J Cell Sci 126(Pt 17):3799-3804, 2013.
79. Hayashida A, Bartlett AH, Foster TJ, Park PW: Staphylococcus aureus betatoxin induces lung injury through syndecan-1. Am J Pathol 174(2):509-518, 2009.
80. Pruessmeyer J, Martin C, Hess FM, Schwarz N, Schmidt S, Kogel T, Hoettecke N, Schmidt B, Sechi A, Uhlig S, et al.: A disintegrin and metalloproteinase 17 (adam17) mediates inflammation-induced shedding of syndecan-1 and-4 by lung epithelial cells. J Biol Chem 285(1):555-564, 2010.
81. Tanino Y, Chang MY,Wang X, Gill SE, Skerrett S, McGuire JK, Sato S, Nikaido T, Kojima T, Munakata M, et al.: Syndecan-4 regulates early neutrophil migration and pulmonary inflammation in response to lipopolysaccharide. Am J Respir Cell Mol Biol 47(2):196-202, 2012.
82. Li Q, Park PW, Wilson CL, Parks WC: Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111(5):635-646, 2002.
83. Venge P, Pedersen B, Hakansson L, Hallgren R, Lindblad G, Dahl R: Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis. Am J Respir Crit Care Med 153(1):312-316, 1996.
84. Wang Q, Teder P, Judd NP, Noble PW, Doerschuk CM: CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. Am J Pathol 161(6):2219-2228, 2002.
85. Liang J, Jiang D, Griffith J, Yu S, Fan J, Zhao X, Bucala R, Noble PW: CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol 178(4):2469-2475, 2007.
86. van der Windt GJ, Florquin S, de Vos AF, van't Veer C, Queiroz KC, Liang J, Jiang D, Noble PW, van der Poll T: CD44 deficiency is associated with increased bacterial clearance but enhanced lung inflammation during Gram-negative pneumonia. Am J Pathol 177(5):2483-2494, 2010.
87. Lennon FE, Singleton PA: Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology. Am J Physiol Lung Cell Mol Physiol 301(2):L137-L147, 2011.
88. Schmidt EP, Li G, Li L, Fu L, Yang Y, Overdier KH, Douglas IS, Linhardt RJ: The circulating glycosaminoglycan signature of respiratory failure in critically ill adults. J Biol Chem 289(12):8194-8202, 2014.
89. Smith ML, Long DS, Damiano ER, Ley K: Near-wall micro-PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophys J 85(1):637-645, 2003.
90. Ebong EE, Macaluso FP, Spray DC, Tarbell JM: Imaging the endothelial glycocalyx in vitro by rapid freezing/freeze substitution transmission electron microscopy. Arterioscler Thromb Vasc Biol 31(8):1908-1915, 2011.
91. Mulivor AW, Lipowsky HH: Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol 283(4):H1282-H1291, 2002.
92. Zeng Y, Ebong EE, Fu BM, Tarbell JM: The structural stability of the endothelial glycocalyx after enzymatic removal of glycosaminoglycans. PLoS One 7(8):e43168, 2012.
93. Yen WY, Cai B, Zeng M, Tarbell JM, Fu BM: Quantification of the endothelial surface glycocalyx on rat and mouse blood vessels. Microvasc Res 83(3):337-346, 2012.
94. Job KM, Dull RO, Hlady V: Use of reflectance interference contrast microscopy to characterize the endothelial glycocalyx stiffness. Am J Physiol Lung Cell Mol Physiol 302(12):L1242-L1249, 2012.
95. Giantsos KM, Kopeckova P, Dull RO: The use of an endothelium-targeted cationic copolymer to enhance the barrier function of lung capillary endothelial monolayers. Biomaterials 30(29):5885-5891, 2009.
96. Giantsos-Adams K, Lopez-Quintero V, Kopeckova P, Kopecek J, Tarbell JM, Dull R: Study of the therapeutic benefit of cationic copolymer administration to vascular endothelium under mechanical stress. Biomaterials 32(1):288-294, 2011.